Black Titan Corp (NASDAQ:BTTC) Sees Large Increase in Short Interest

Black Titan Corp (NASDAQ:BTTC) saw a large increase in short interest in September. As of September 30th, there was short interest totaling 324,159 shares, an increase of 2,988.7% from the September 15th total of 10,495 shares. Approximately 6.5% of the company’s stock are sold short. Based on an average daily trading volume, of 49,519,007 shares, the days-to-cover ratio is currently 0.0 days.

Black Titan Stock Down 3.9%

Shares of Black Titan stock traded down $0.02 on Friday, reaching $0.48. 454,634 shares of the company were exchanged, compared to its average volume of 4,384,786. The stock’s 50 day moving average price is $0.55 and its 200-day moving average price is $0.89. The company has a market cap of $5.13 million, a P/E ratio of -0.16 and a beta of 1.11. Black Titan has a 1-year low of $0.34 and a 1-year high of $10.05. The company has a debt-to-equity ratio of 0.06, a current ratio of 4.62 and a quick ratio of 4.62.

Black Titan Company Profile

Titan Pharmaceuticals, Inc is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.